Monday's top brokerage calls: Lupin, ICICI Bank and more

SUMMARY

Among brokerages, CLSA is negative on Lupin while Macquarie upgraded the stock to 'neutral' after its Q3 earnings. Meanwhile, UBS, as well as Macquarie, are bullish on ICICI Bank after its December quarter results. Here are the top brokerage calls for today:

By CNBCTV18.comFeb 1, 2021 8:54:03 AM IST (Published)

CLSA on Lupin: The brokerage maintains a 'sell' call on the stock with a target at Rs 990 per share. It raised its FY21-22 EPS estimates by 3-6 percent.

Macquarie on Lupin: The brokerage upgraded the stock to 'neutral' with a target at Rs 980 per share. The upgrade was on the back of improving execution and higher visibility on niche launches.

Macquarie on ICICI Bank: The brokerage has an 'outperform' call on the stock with a target at Rs 700 per share.

UBS on ICICI Bank: The brokerage has a 'buy' rating on the stock with a target at Rs 700 per share. It increased earnings estimates for FY21 and FY22 by 5 percent and 2 percent, respectively.

Credit Suisse on Tata Motors: The brokerage has a 'neutral' call on the stock with a target at Rs 239 per share. It added that full valuations, mix and cost headwinds, market share and EV concerns keep the stock on the sidelines.

Kotak on Tata Motors: The brokerage has a 'sell' call on the stock but raised the target to Rs 180 per share from Rs 155 earlier.

Goldman Sachs on Dr Reddy's: The brokerage is 'neutral' on the stock with a target at Rs 4,890 per share. It lowered FY22-24 EPS estimates for the firm by up to 4 percent.

CLSA on Dr Reddy's: The brokerage has a 'buy' call on the stock with a target at Rs 5,830 per share. It sees sustained growth and margin improvement in EMs driving mid-teen earnings growth.

Macquarie on Tech Mahindra: The brokerage has an 'outperform' rating for the stock with a target at Rs 1,190 per share. It added that Q3 results were ahead of estimates led by a stronger than expected margin.

Citi on IndusInd Bank: The brokerage maintains a 'buy' call on the stock with a target at Rs 1,175 per share. However, it lowered FY21-23 profit estimates by 5-13 percent.

Morgan Stanley on SAIL: The brokerage is 'equal-weight' on the stock with a target at Rs 66 per share

Citi on Tata Steel: The brokerage has a 'buy' call on the stock with a target at Rs 850 per share.

CLSA on Sun Pharma: The brokerage has a 'buy' call on the stock with a target at Rs 760 per share. It raised its FY22-23 EPS estimates for the company.